In this issue:

  • HIV DNA vaccines move slowly into human trials
  • IAVI Launches Scientific Blueprint
  • The Outlook for Key HIV DNA Vaccine Programs
  • An Interview with Margaret Liu
  • AIDS in South Africa
  • South Africa's Explosive AIDS Epidemic
  • VaxGen gets Approval for U.S. Efficacy Study
  • Industry Insider
  • Vaccine Briefs